Hikma Pharmaceuticals (HIK) Finalizes $250 Million Share Buyback Program with Completion of Second Tranche

Hikma Pharmaceuticals (HIK) Finalizes $250 Million Share Buyback Program with Completion of Second Tranche →

Hikma Pharmaceuticals PLC (LSE: HIK) has announced the successful completion of its $250 million share repurchase program, initially disclosed on 26 February 2026, following the conclusion of the second and final tranche of ordinary share a…